Elevance Health: Assessing Prospects After Q3 Earnings Beat
seekingalpha.com
news
2022-10-20 03:30:47

andresr/E+ via Getty Images Elevance Health (NYSE:ELV) released its third-quarter earnings report on Wednesday and strolled past expectations, beating its earnings estimate by 38 cents per share. However, Elevance Health's stellar third-quarter performance comes as no surprise to us. A little over a year ago, we assigned a buy rating to the stock based on its robust earnings trajectory and lucrative dividend profile. After careful consideration, we've decided to upgrade Elevance Health stock to a strong buy; here's why.
